Liquidia Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LQDA research report →
Companywww.liquidia.com
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States.
- CEO
- Roger A. Jeffs
- IPO
- 2018
- Employees
- 170
- HQ
- Morrisville, NC, US
Price Chart
Valuation
- Market Cap
- $5.49B
- P/E
- 243.72
- P/S
- 19.07
- P/B
- 50.07
- EV/EBITDA
- 104.86
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 91.78%
- Op Margin
- 15.81%
- Net Margin
- 7.74%
- ROE
- 46.82%
- ROIC
- 12.79%
Growth & Income
- Revenue
- $158.32M · 1031.18%
- Net Income
- $-68,924,000 · 47.14%
- EPS
- $-0.80 · 51.81%
- Op Income
- $-51,376,000
- FCF YoY
- 59.32%
Performance & Tape
- 52W High
- $62.15
- 52W Low
- $11.85
- 50D MA
- $40.69
- 200D MA
- $32.82
- Beta
- 0.42
- Avg Volume
- 1.47M
Get TickerSpark's AI analysis on LQDA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | JEFFS ROGER | sell | 25,000 |
| May 14, 26 | JEFFS ROGER | sell | 25,000 |
| May 15, 26 | JEFFS ROGER | sell | 25,000 |
| May 11, 26 | Bloch Stephen M | sell | 75,801 |
| May 11, 26 | Bloch Stephen M | sell | 115,479 |
| May 11, 26 | Bloch Stephen M | sell | 27,613 |
| May 11, 26 | Bloch Stephen M | sell | 10,500 |
| May 11, 26 | Bloch Stephen M | sell | 75,293 |
| May 11, 26 | Bloch Stephen M | sell | 14,207 |
| May 8, 26 | JEFFS ROGER | sell | 25,000 |
Our LQDA Coverage
We haven't published any research on LQDA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LQDA Report →